ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,996.66
1.00%
Dow Jones
43,487.83
0.78%
US Dollar vs MXN
20.72915
1.10%
Brent Oil
79.295
0.09%
Bitcoin
101,523.46
-0.49%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE

  6. Syros Pharmaceuticals Inc (0LC7) Cotización

Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc (0LC7)

LSE
11.96
0.00
(0.00%)
Cerrado 20 Enero 10:30AM
Delayed by 15 minutes

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Estadísticas y detalles clave

Último Precio
11.96
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
0.00
0.00 Rango del Día 0.00
11.96 Rango de 52 semanas 11.96
Capitalización de Mercado [m]
251.961M
Precio Anterior
11.96
Precio de Apertura
-
Hora
250
@
0.21
(O)
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
806,131
Acciones en circulación
21,067,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-0.03
Beneficio por acción (BPA)
-7.81
turnover
9.94M
Beneficio neto
-164.57M

Acerca de Syros Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.syros.com
Sede
Wilmington, Delaware, USA
Fundado
-
Syros Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0LC7. The last closing price for Syros Pharmaceuticals was US$11.96. Over the last year, Syros Pharmaceuticals shares have traded in a share price range of US$ 11.96 to US$ 11.96.

Syros Pharmaceuticals currently has 21,067,000 shares in issue. The market capitalisation of Syros Pharmaceuticals is US$251.96 million. Syros Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.03.

0LC7 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10011.9611.9611.963511111.96DE
40011.9611.9611.9670924811.96DE
120011.9611.9611.9680613111.96DE
260011.9611.9611.9637466211.96DE
520011.9611.9611.9618893011.96DE
1560011.9611.9611.966367111.96DE
2600011.9611.9611.963804411.96DE

0LC7 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Syros Pharmaceuticals?
El precio actual de las acciones de Syros Pharmaceuticals es US$ 11.96
¿Cuántas acciones de Syros Pharmaceuticals están en circulación?
Syros Pharmaceuticals tiene 21,067,000 acciones en circulación
¿Cuál es la capitalización de mercado de Syros Pharmaceuticals?
La capitalización de mercado de Syros Pharmaceuticals es USD 251.96M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Syros Pharmaceuticals?
Syros Pharmaceuticals ha negociado en un rango de US$ 11.96 a US$ 11.96 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Syros Pharmaceuticals?
El ratio precio/beneficio de Syros Pharmaceuticals es -0.03
¿Cuál es el ratio de efectivo a ventas de Syros Pharmaceuticals?
El ratio de efectivo a ventas de Syros Pharmaceuticals es 0.47
¿Cuál es la moneda de reporte de Syros Pharmaceuticals?
Syros Pharmaceuticals presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Syros Pharmaceuticals?
El último ingresos anual de Syros Pharmaceuticals es USD 9.94M
¿Cuál es el último beneficio anual de Syros Pharmaceuticals?
El último beneficio anual de Syros Pharmaceuticals es USD -164.57M
¿Cuál es la dirección registrada de Syros Pharmaceuticals?
La dirección registrada de Syros Pharmaceuticals es CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Syros Pharmaceuticals?
La dirección del sitio web de Syros Pharmaceuticals es www.syros.com
¿En qué sector industrial opera Syros Pharmaceuticals?
Syros Pharmaceuticals opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WSLWorldsec Ld
2.00p
(60.00%)
105.37k
BLUBlue Star Capital Plc
12.00p
(45.45%)
1.54M
NTQEnteq Technologies Plc
1.40p
(40.00%)
19.81M
BANKFiinu Plc
10.25p
(36.67%)
12.95M
TIRTiger Royalties And Investments Plc
0.16p
(28.00%)
139.07M
PODPPod Point Group Holdings Plc
10.88p
(-35.20%)
6.83M
PALMPanther Metals Plc
53.50p
(-35.15%)
226.06k
NOGNostrum Oil & Gas Plc
2.51p
(-23.82%)
117.6k
ADMEAdm Energy Plc
0.175p
(-22.22%)
1.19M
PRDPredator Oil & Gas Holdings Plc
5.85p
(-20.95%)
5.72M
NTVONativo Resources Plc
0.0021p
(10.53%)
844.9M
TRPTower Resources Plc
0.0305p
(-1.61%)
507.22M
PREMPremier African Minerals Limited
0.027p
(-3.57%)
504.81M
SYMESupply@me Capital Plc
0.003p
(-13.04%)
461.39M
ORCPOracle Power Plc
0.016p
(-5.88%)
308.68M

Discusión

Ver feed completo
RobotDroid RobotDroid 4 minutos hace
Let the lawsuits begin.
NWBO
janice shell janice shell 4 minutos hace
Melania is no Theodora! Theodora was talented, and brilliant. Justinian was smart, unlike Trumpty. And he actually loved Theodora, and she, him. He treated her as an equal, and was devastated when she died of breast cancer.

Procopius and some other ancient writers had their own reaso
Viking61 Viking61 5 minutos hace
Up up and away🚀🚀🚀🚀
FNMA
DTGoody DTGoody 6 minutos hace
THE AGE OF THE GOLDEN DAWN BEGINS IN AMERICA! TRUMP'S REIGN WILL USHER IN THE LUCIFERIAN DOCTRINE!

https://youtu.be/WzaAHsMXAC4
cashclan cashclan 6 minutos hace
Hmmm...



Joint venture ...thoughts


Tic toc
PTEL
Stock_Barber Stock_Barber 8 minutos hace
only a loss when sell
That is the bagholder's manta!

It doesn't help when traders see the hole in their portfolio!

💩
DBMM
mascale mascale 9 minutos hace
Versus Jack_Herer poster alleged "MBA:" The claim is that this does not exist at Hiru(?), from which it is sourced. Company reports that this too, is in audit. https://www.otcmarkets.com/otcapi/company/financial-report/414918/content
HIRU
1manband 1manband 10 minutos hace
I don't. But I would also like to know. Either he is being thrown under the bus, or his lack of knowledge of the regulations put himself there.
MIchaeljohn MIchaeljohn 10 minutos hace
Bought 27,000 shares
Change is gonna come!
WKSP
delerious1 delerious1 10 minutos hace
Sorry , I'd like to help but it looks hopeless trying to explain things to you , so good luck in your investing, looks like you'll need it LMFAO....OMG

NBRI Rocks !!!!
NBRI
looking 4 a win looking 4 a win 11 minutos hace
DOGE is the future, not Kardashian Koin or whatever the fuck. 
DOGEUSD
jimr1717 jimr1717 11 minutos hace
There are restricted shares coming off of restriction. I would expect more new posters joining in to try and hold up the price until their “unload date”.

Only Fools are Fooled
IFUS
Real McCoy Real McCoy 13 minutos hace
The company/monitor/courts/preSS/FINRA settled it. Right?
elks elks 13 minutos hace
Thanks info
WDLF
gitreal gitreal 13 minutos hace
You can't answer. Or won't answer.

The quote from Jared was quite clear, he supposedly said that their ore was worth less than $100/ton, therefore, paying $25/ton won't matter much (25% tariff rate).

How is that twisting the facts? Was Rodeo guy lying, or was Jar
NBRI
Imindog Imindog 13 minutos hace
Dip chit they ban me from stock twits so I post on this board lol!! The only way I jump back in this pos after losing 80k on this pos is to short the hell out of it right when they do the reverse splitski soon!! Timing is everything and this week or next is going to be brutal just like last week was
IQST
KILLAZILLA KILLAZILLA 14 minutos hace
PARTNERS(LYING GRIFFERS) IN SCAM!!!

SOME PEEPS ARE JUST THAT GULLIBLE....
XERI
delerious1 delerious1 15 minutos hace
Seriously what's not to like....all this in a few months....and....getting good grades....😎🔨
NBRI
crescentmotor crescentmotor 15 minutos hace
Or never, that probability is very high...

Behold, the one with already proven ignorance when it comes to AVXL speaks again.
AVXL
stockinspector stockinspector 15 minutos hace
Cryin' crocodile tears all the way to the bank. Has multi millions of shares already
and coming for more. They aren't even smart enough to let their sob story settle
before the next volley of fertilizer is delivered. Just spilling the story on your dirty tactics with no regret.
WDLF
train train 16 minutos hace
Anybody on this board know when these warrants expire????????

I would like to add some more.

Charlie
Williamsburg, Va.
BFGFF
boi568 boi568 17 minutos hace
The AP is reporting that the new administration is ordering a temporary freeze on new regulations, as I predicted.

This will likely extend to guidances, as well. It is possible that material already set with the Federal Register for publication tomorrow may get through as already done
AVXL
delerious1 delerious1 18 minutos hace
"Just tell us whether you think it makes sense to ship ore worth less than $100/ton. "....again you are twisting the facts....I can see why you steer away from investing LOL
NBRI
Dingbatt Dingbatt 18 minutos hace
This is how we do it all hands are in the air

https://www.youtube.com/live/aQXg3Lcj1zk?si=yQFo8c28z0IVam8Q
GNCP
OMOLIVES OMOLIVES 19 minutos hace
Yep. You wouldn't happen to know the name of his money manager at that time..eh? The one cited. I am dying to know.

Su Consulta Reciente

LSE
0LC7
Syros Pharmaceuticals
LSE
0JWM
Societe Industrielle Et ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados